Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 15 citing articles:

The Menin story in acute myeloid leukaemia—The road to success
Michael W.M. Kühn, Arnold Ganser
British Journal of Haematology (2024) Vol. 205, Iss. 3, pp. 812-814
Open Access | Times Cited: 10
Menin Inhibitors: New Targeted Therapies for Specific Genetic Subtypes of Difficult-to-Treat Acute Leukemias
Pasquale Niscola, Valentina Gianfelici, Marco Giovannini, et al.
Cancers (2025) Vol. 17, Iss. 1, pp. 142-142
Open Access
Application of RNA-Based Next-Generation Sequencing Fusion Assay for Hematological Malignancies
Fei Fei, Milhan Telatar, Vanina Tomasian, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 435-435
Open Access
A comprehensive high-throughput screening approach for discovering inhibitors targeting the menin-MLL1 interaction
Tamizhini Loganathan, C. George Priya Doss
Advances in protein chemistry and structural biology (2025), pp. 69-95
Closed Access
Targeting Protein–Protein Interactions in Hematologic Malignancies
Tomasz Cierpicki, Jolanta Grembecka
Annual Review of Pathology Mechanisms of Disease (2025) Vol. 20, Iss. 1, pp. 275-301
Closed Access
A rapid and green analytical strategy to determine menin inhibitor revumenib in human blood serum via CE-DAD
Sergio Fernández-Trujillo, Gregorio Castañeda, Juana Rodrı́guez, et al.
Microchemical Journal (2025), pp. 113119-113119
Closed Access
Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric Leukemia
Ke Wang, Shayan Saniei, Nikita Poddar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Oral decitabine in acute myeloid leukemia: assessing efficacy, safety, and future implications for older patients
Pasquale Niscola
Expert Review of Hematology (2025)
Closed Access
Molecular Features and Treatment Paradigms of Acute Myeloid Leukemia
Mihir Shukla, Maher Abdul‐Hay, Jun‐Hui Choi
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1768-1768
Open Access | Times Cited: 2
Menin in Cancer
Ariana D. Majer, Xianxin Hua, Bryson W. Katona
Genes (2024) Vol. 15, Iss. 9, pp. 1231-1231
Open Access | Times Cited: 2
Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies
Pasquale Niscola, Valentina Gianfelici, Gianfranco Catalano, et al.
Current Oncology (2024) Vol. 31, Iss. 11, pp. 6632-6658
Open Access | Times Cited: 1
Targeting chromatin modifying complexes in acute myeloid leukemia
Alexandra Schurer, Shira Glushakow-Smith, Kira Gritsman
Stem Cells Translational Medicine (2024)
Open Access | Times Cited: 1
Histone methyltransferase KMT2A: Developmental regulation to oncogenic transformation
Jayme Ogino, Yali Dou
Journal of Biological Chemistry (2024), pp. 107791-107791
Open Access
Menin-mll protein-protein interaction inhibitors: a patent review (2021-present)
Fang Wang, Zhe Yang, Yujie Wu, et al.
Expert Opinion on Therapeutic Patents (2024), pp. 1-14
Closed Access
Design of Potent Menin–KMT2A Interaction Inhibitors with Improved In Vitro ADME Properties and Reduced hERG Affinity
Bruno D. Chapsal, J. Kimbrough, S.M. Bester, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 16, Iss. 2, pp. 224-233
Closed Access
NEW DRUGS ON THE PHARMACEUTICAL MARKET CONTAINING FLUORINE AND RESIDUES OF TAILOR-MADE AMINO ACIDS
Jianlin Han, Alicja Wzorek, Gagan Dhawan, et al.
Ukrainian Chemistry Journal (2024) Vol. 90, Iss. 9, pp. 31-56
Open Access
Page 1

Scroll to top